On Demand Webinars
Upstream Viral Risk Mitigation Strategy for High Titer Biologics Manufacturing
Presented by Aaron Mack, Engineer at Biogen and Dave Kolwyck, Director Materials Science at Biogen and David Gemmell Senior Process Engineer at Merck
17th October 2019
FDA Perspective on Aseptic Process Simulation for Cell Therapy Product Manufacturing
Presented by Lily Koo, Consumer Safety Officer at Food and Drug Administration and Keen Chung, Principal Scientist (Upstream Process) at Pall Biotech, Analytics Lead
16th October 2019
Qualification of Raw Materials Used In the Manufacturing of Cellular Therapies
Presented by Jim Richardson, Sr Scientific Liaison at United States Pharmacopeia and Horst Ruppach, Ph.D. Scientific Director Viral Safety at Charles River
07th October 2019
Cost Considerations for the Application of Continuous Processing
Presented by Narasimha Rao Nedunuri, CEO of CLONZ Biotech and Tania Pereira Chilima, Product Manager at Univercells
02nd October 2019
Characterization of Biotherapeutics
Presented by Diane McCarthy, PhD, Senior Scientific Liaison, Global Biologics, US Pharmacopeia and Dr Kai Scheffler, Product Manager at Thermo Fisher Scientific
24th September 2019
How to Utilize Design of Experiments (DoE) Principles for the Development of High Throughput, Robust Methods for the Assessment of Product Quality
Presented by Jeremy Springall PhD, Scientist II, Analytical Sciences, R&D Biopharmaceutical Development, AstraZeneca
19th September 2019
From Concept to Market – Unique approaches in Biomanufacturing
Presented by Jincai Li, Vice President of WuXi Biologics and Kevin Mullen, Sr. Product Manager, Single-Use Systems at Thermo Fisher Scientific
18th September 2019
Big Data Strategies for Cell Therapy Manufacturing
Presented by Scott R. Burger, MD, Principal, Advanced Cell & Gene Therapy, LLC And Heidi Hagen, Co-founder and Chief Strategy Officer for Vineti Inc
17th September 2019
Alternative And Rapid Microbiological Methods: Microbiology Of The 21st Century
Presented by Presented by Dr Benoit Ramond, Head of Microbiology & Sterile Technology, Sanofi and Dr. David Jones, Director of New Products & Industry Affairs at Rapid Micro Biosystems
12th September 2019
Case Study and Experience on Sanofi’s and SGS’s Implementation of BPOG’s Leachable Risk Assessment Model
Presented by Ken Wong, Deputy Director at Sanofi Pasteur and Dujuan Lu, Manager/Global Lead of E&L at SGS
10th September 2019
